All In Biotech

Drug Trial Radar · NCT06414954

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 Over 21 Days in Adult Patients With AChR/MuSK-Ab+ Myasthenia Gravis

Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

84

Planned (sponsor's estimate)

Start

May 16, 2024

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
NMD Pharma A/SIndustry
Sponsor type
Industry
First posted
May 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 2 proof-of-concept, dose range finding study aims to evaluate the safety and efficacy of 3 dose levels of NMD670 vs placebo in adult patients with MG with antibodies against AChR or MuSK, administered twice a day (BID) for 21 days.

Conditions

  • Myasthenia Gravis
  • Myasthenia Gravis, MuSK

Interventions

  • NMD670Drug

    Tablets taken twice a day for 21 days

  • PlaceboDrug

    Tablets taken twice a day for 21 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to day 21 in QMG total score for NMD670 vs placeboTime frame: Baseline to day 21

Locations

40 sites in 10 countries. Site status is shown where the registry gives one.

  • Profound Research LLC

    Carlsbad, California · Withdrawn

  • University of California Irvine Medical Center

    Irvine, California · Recruiting

  • University of Colorado Neuromuscular Division

    Aurora, Colorado · Recruiting

  • SFM Clinical Research, LLC

    Boca Raton, Florida · Recruiting

  • Neuromuscular Research Division | University of South Florida

    Tampa, Florida · Recruiting

  • Augusta University, Neuroscience Center

    Augusta, Georgia · Recruiting

  • NextGen Precision Health

    Columbia, Missouri · Recruiting

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Recruiting

  • The Ohio State University

    Columbus, Ohio · Recruiting

  • University of Oregon

    Portland, Oregon · Recruiting

  • Semmes Murphey Clinic

    Memphis, Tennessee · Withdrawn

  • UZ Leuven

    Leuven, Belgium · Withdrawn

  • Aarhus University Hospital

    Aarhus, Denmark · Recruiting

  • Rigshospitalet University of Copenhagen

    Copenhagen, Denmark · Recruiting

  • Centre de référence des maladies neuromusculaires AOC-CHU de Bordeaux - Hôpital Pellegrin

    Bordeaux, France · Recruiting

  • Centre de Référence des Maladies Neuromusculaires et de la SLA

    Marseille, France · Recruiting

  • Centre Hospitalier Universitaire de Nantes - Hôtel Dieu Centre de Référence des Maladies Neuromusculaires Rares -

    Nantes, France · Recruiting

  • CHU de Nice

    Nice, France · Recruiting

  • Unité de Recherche Clinique NeuroSciences

    Nice, France · Recruiting

  • JSC Curatio

    Tbilisi, Georgia · Active not recruiting

  • LTD David Tatishvili Health Center

    Tbilisi, Georgia · Active not recruiting

  • Ltd New Hospitals

    Tbilisi, Georgia · Active not recruiting

  • ASST Papa Giovanni XXIII (Azienda Ospedaliera Papa Giovanni XXIII)

    Bergamo, Italy · Recruiting

  • IRCCS Istituo delle Scienze neurologiche di Bologna, UOC Clinica neurologica Ospedale

    Bologna, Italy · Recruiting

  • IRCCS Ospedale Policlinico San Martino

    Genova, Italy · Recruiting

  • IRCCS Fondazione Istituto Neurologico Carlo Besta, Dipartimento di Ricerca e Sviluppo clinico

    Milan, Italy · Recruiting

  • DIMER, IRCCS, Ospedale San Raffaele

    Milan, Italy · Recruiting

  • Centro Sclerosi Multipla Napoli - AOU Vanvitelli

    Naples, Italy · Recruiting

  • AOU Pisana

    Pisa, Italy · Recruiting

  • Azienda Ospedaliera Sant'Andrea - Universita di Roma La Sapienza

    Roma, Italy · Recruiting

  • Leiden Universitair Medisch Centrum (LUMC)

    Leiden, Netherlands · Recruiting

  • Neurologia Śląska Centrum Medyczne

    Katowice, Poland · Recruiting

  • Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie sp.z o.o

    Krakow, Poland · Recruiting

  • Centrum Medyczne Hope Clinic

    Lublin, Poland · Recruiting

  • Galen Clinic

    Lublin, Poland · Recruiting

  • NeuroCor Banaszkiewicz, Tomaszewski Lekarze Spółka Partnerska

    Myślenice, Poland · Recruiting

  • Centrum Medyczne Neuro Protect

    Warsaw, Poland · Recruiting

  • University Clinical Center of Serbia, Neurology Clinic

    Belgrade, Serbia · Withdrawn

  • University Clinical Center Nis, Neurology Clinic

    Niš, Serbia · Recruiting

  • Hospìtal Universitari Vall d'Hebrón

    Barcelona, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.